Captor Capital Announces Availability of Updated Investor Presentation

TORONTO, May 14, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; USOTC: CPTRF; FRANKFURT: NMV; STUTTGART: NMVA;), (“Captor” or the “Company”), a vertically integrated cannabis investment company, is pleased to announce that a new investor presentation will be available on the Company website as of 9:00 a.m. today, May 14. The updated presentation is being released in conjunction with…

Read More

Captor Capital Enters Into Letter of Intent to Acquire Majority Ownership in Michigan Cannabis Opportunity

captor

April 09, 2019 07:59 ET | Source: Captor Capital Corp. 20 retail cannabis licenses Two processing licenses Eight cultivation licenses TORONTO, April 09, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; USOTC: CPTRF; FRANKFURT: NMV; STUTTGART: NMVA), (“Captor” or the “Company”), a vertically integrated investment company focused on cannabis, is pleased to announce that it has entered into a…

Read More

Captor Capital Announces Letter of Intent to Acquire Premiere THC Manufacturing Facility from People’s Holdings

Captor Capital Shares

TORONTO, March 29, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), a vertically integrated cannabis-focused investment company, is pleased to announce that a wholly owned subsidiary of the Company has entered into a Letter of Intent (“LOI”) to acquire 100 per cent ownership of a Type 7 Volatile Solvent…

Read More

WCVC Announces Continued EVERx CBD Sports Water Sales Growth

West Coast Venture Group, Corp.

DENVER, March 28, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — West Coast Venture Group, Corp. (OTCQB: WCVC) (“WCVC”) today announced the company is enjoying continued growth of EVERx CBD Sports Water since introducing the beverage in its Illegal Burger restaurants last month.  WCVC yesterday placed its third restock order this year.  EVERx CBD Sports Water is produced by…

Read More

Cannabis Stock Battle: Aurora Cannabis Inc (TSX:ACB) or Green Organic Dutchman Holdings Ltd (TSX:TGOD)?

It’s no secret that the cannabis industry is blowing up. Earlier this year, investors received hard numbers to support the hype. In 2018, more than five million Canadians purchased cannabis worth at least $6 billion. Over the next few years, spending is expected to reach $9 billion in Canada alone. Increased spending in the U.S. could more than triple that…

Read More

KALY Announces A New Step Forward For Its Cannabis Extraction Lab

Kaly1

DALLAS, March 26, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the State of Texas plans to remove hemp as a controlled substance next week in conjunction with the United States 2018 Farm Act, just the type of market condition management is looking for to support the…

Read More

USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY

North American Cannabis Holdings, Inc.

DALLAS, March 22, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Puration Inc. (USOTC: PURA) (“PURA”) today published an update on the progress the two companies are making toward their respective planned dividend distributions. USMJ and PURA are sister companies sharing the same majority shareholder, ACI Conglomerated. In the 4th…

Read More

KALY Publishes Cannabis Extract COPD Treatment Study Report

Kali Extracts

DALLAS, Feb. 05, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published a preview of the recently announced long-term, pilot study on the treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates with cannabis extracts derived from Kali-Extracts patented cannabis extraction process. The study adds to the Kali-Extracts in…

Read More

KALY Confirms Pharmaceutical Cannabis Extract Report On Recent Trials Scheduled For Tomorrow

Kaly1

DALLAS, March 21, 2019 (GLOBE NEWSWIRE) — — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company plans to publish its phase one research on the pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates. The primate study adds to the Kali-Extracts in vitro genomics study, previously announced, to evaluate…

Read More

KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019

Kali Extracts

DALLAS, March 20, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company plans to publish its phase one research on the pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates. The research paper comes from Professor Jeffry Osbourn, Ph.D., from the University of Kentucky and the…

Read More